Medtronic, Inc. announced completion of enrollment in the TTOP-AF (Tailored Treatment of Permanent Atrial Fibrillation) clinical trial. The study is evaluating the use of the Medtronic Ablation Frontiers Cardiac Ablation System, for the treatment of continuous atrial fibrillation.
Clinical Trials
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
At six months, the NEVO™ Sirolimus-eluting Coronary Stent, incorporating RES Technology™, was superior to the Taxus® Liberte® Stent in reducing tissue growth within the stent that can potentially lead to repeat procedures, in new clinical study results released today.
Results of Medtronic-Supported implantable cardioverter-defibrillator (ICD) Clinical Trial
MVP® (Managed Ventricular Pacing), exclusive programming on Medtronic pacemakers was applied in the MVP Trial of implantable cardioverter-defibrillator patients.
Endosense Unveils TOCCATA Trial Results: The First Complete Assessment Of Force In Catheter Ablation
Endosense has announced the release of acute clinical results from the TOCCATA (TOuCh+ for CATheter Ablation) European clinical trial at Heart Rhythm 2009, the Heart Rhythm Society’s 30th Annual Scientific Sessions in Boston, May 13 – 16.
Enrollment Complete For Medtronic Clinical Trial Evaluating Radiofrequency Ablation Tools
Medtronic, Inc. today announced completion of enrollment in the TTOP-AF (Tailored Treatment of Permanent Atrial Fibrillation) clinical trial.
Medtronic Demonstrates Positive Results On First Pacemaker Designed For Use With MRI
New data announced at Heart Rhythm 2009, the annual congress of the Heart Rhythm Society, demonstrate that patients implanted with the investigational EnRhythm MRI™ SureScan™ pacing system experienced no complications related to the use of magnetic resonance imaging.
Medtronic Device Registry First To Show How Implantable Heart Devices Work In Real-World
The first results from the Medtronic Inc. OMNI Study were released at Heart Rhythm 2009, revealing that one out of six patients received potentially life-saving medical therapy within the two years following their implant.
Medtronic Announces U.S. Trial Of Unique Therapy For Closure Of The Left Atrial Appendage
Medtronic, Inc. announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Device as part of a U.S. clinical trial.
Article Reports Fewer Repeat Procedures With Boston Scientific’s TAXUS® Liberte® Stent
Journal of American College of Cardiology reports fewer repeat procedures with Boston Scientific’s TAXUS® Liberte® Paclitaxel-Eluting Stent compared to patients treated with ‘olimus-based drug-eluting stents.
New Study Shows that Zilver PTX from Cook Medical Effectively Treats Blockages in Critical Thigh Artery
Preliminary data presented today at the 32nd annual SCAI Scientific Sessions show that 82 percent of patients treated with Cook Medical’s Zilver® PTX™ drug-eluting peripheral stent were free from reintervention at two-year follow up.
SCAI Highlights Cardiac Dimensions Inc AMADEUS Study as an Important “Late Breaking” Clinical Trial
The Society of Cardiovascular Angiography and Interventions will highlight Cardiac Dimensions®, Inc.’s AMADEUS™ study during its 32nd annual scientific sessions held in Las Vegas, NV later this week.
Cementless Hip Implants Are Durable For At Least 20 Years
Despite the common perception that total hip replacements last about 10 years, researchers at Rush University Medical Center have found that the devices are extremely durable, even 20 years after surgery.
ISTO Technologies, Inc. Announces FDA Approval to Initiate a Clinical Trial for a Novel Treatment for Disc Nucleus Regeneration
STO Technologies, Inc. announced today that it has received notification from the U.S. Food and Drug Administration allowing the company to proceed with a Phase I clinical study for NuQu™, a cell-based injectable formulation of juvenile chondrocytes designed to regenerate cartilage, restore disc function and relieve discogenic back pain.
Transoma Medical Announces First Patient Enrollment in Clinical Study on Atrial Fibrillation
Transoma Medical, Inc. announced the first enrollment and implant in a long-term study to monitor patients who have suffered a cryptogenic stroke (of unknown origin) to determine if atrial fibrillation is present.
Study Assesses New Surgical Procedure For Regenerating Cartilage In Damaged Knee Joints
Rush University Medical Center is testing a new procedure for regenerating damaged articular cartilage in the knee joint to relieve the pain of osteoarthritis.
Medtronic Initiates Global Abdominal Aortic Aneurysm Study
Medtronic, Inc. today announced the start of ENGAGE¹, the largest ever study of its kind, which will evaluate the performance of the Endurant stent graft, an implantable medical device designed to provide an advanced minimally-invasive alternative to open surgical repair of abdominal aortic aneurysms.